Somatostatin analogues (SSA) represent one of the main therapeutic option in patients affected with functioning well-differentiated neuroendocrine tumours (NETs). There are no studies specifically focusing on NETs associated with Multiple Endocrine Neoplasia type 1 (MEN1).

Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours / Ramundo, V; Del Prete, M; Marotta, V; Marciello, F; Camera, L; Napolitano, V; De Luca, L; Circelli, L; Colantuoni, V; Di Sarno, A; Carratù, A C; de Luca di Roseto, C; Colao, A; Faggiano, A. - In: CLINICAL ENDOCRINOLOGY. - ISSN 1365-2265. - 80:6(2014), pp. 850-855. [10.1111/cen.12411]

Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours

Ramundo, V
Writing – Original Draft Preparation
;
Faggiano, A
2014

Abstract

Somatostatin analogues (SSA) represent one of the main therapeutic option in patients affected with functioning well-differentiated neuroendocrine tumours (NETs). There are no studies specifically focusing on NETs associated with Multiple Endocrine Neoplasia type 1 (MEN1).
2014
Adult; cell differentiation; disease progression; endocrine system; female; gastrins; humans; insulin; male; middle aged; multiple endocrine neoplasia type 1; neuroendocrine tumors; octreotide; retrospective studies; Somatostatin; time factors; treatment outcome
01 Pubblicazione su rivista::01a Articolo in rivista
Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours / Ramundo, V; Del Prete, M; Marotta, V; Marciello, F; Camera, L; Napolitano, V; De Luca, L; Circelli, L; Colantuoni, V; Di Sarno, A; Carratù, A C; de Luca di Roseto, C; Colao, A; Faggiano, A. - In: CLINICAL ENDOCRINOLOGY. - ISSN 1365-2265. - 80:6(2014), pp. 850-855. [10.1111/cen.12411]
File allegati a questo prodotto
File Dimensione Formato  
Faggiano_Impact-of-ocreotide.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 152.88 kB
Formato Adobe PDF
152.88 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1120797
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 33
social impact